An aseptic process simulation (APS), widely known as a media fill, tests whether an aseptic manufacturing process can produce sterile product. The process is run as closely as possible to routine production, but with a sterile microbiological growth medium in place of the product. The filled units are incubated and inspected; any growth shows that contamination entered during processing.
A media fill should simulate the worst-case conditions of routine work: the longest run times, the planned interventions (such as replacing a filling needle), the maximum number of personnel and shift changes. EU GMP Annex 1 expects initial validation runs followed by periodic revalidation of each aseptic process and line — around every six months — and sets a target of zero contaminated units.
Why it matters in GMP
Sterility testing of finished product samples cannot prove that every unit in a batch is sterile. The media fill is the main evidence that the aseptic process itself is under control, which is why regulators treat a failed or expired media fill as a reason to stop aseptic production on that line until it is investigated and requalified.
- Approve a protocol with fill volumes, incubation conditions, interventions and acceptance criteria.
- Account for every unit filled, incubated and found positive.
- Investigate any failure and assess the impact on batches made since the last passing run.
How Swat iQua Suite handles it
Swat iQua Suite manages versioned media-fill protocols with fill volume, incubation, acceptance criteria and validity period, approved by three different people with e-signatures. Each run records units filled, incubated and positive, and any positive unit means the run fails. A passing run sets the line’s valid-until date, and a line-qualification gate blocks aseptic filling on any line without a current passing media fill. A failed run triggers the sterile-impact process.